20.927 articles found

Pick's Disease Presenting as Tremulous Parkinsonism with Limited Levodopa Response-A Rare Cause of Corticobasal Syndrome.

Bhattacharjee S, Scotton W, Djoukhadar I, Davidson YS, Minshull J, Robinson AC, Roncaroli F, Kobylecki C.

Mov Disord Clin Pract · 2024-06-03

DOI: 10.1002/mdc3.14125PMID: 38826096

Potassium and calcium channels in different nerve cells act as therapeutic targets in neurological disorders.

Qiu Q, Yang M, Gong D, Liang H, Chen T.

Neural Regen Res · 2024-06-03

DOI: 10.4103/nrr.nrr-d-23-01766PMID: 38845230

Discovery of novel benzimidazole derivatives as selective and reversible monoamine oxidase B inhibitors for Parkinson's disease treatment.

Lv Y, Fan M, He J, Song X, Guo J, Gao B, Zhang J, Zhang C, Xie Y.

Eur J Med Chem · 2024-06-02

DOI: 10.1016/j.ejmech.2024.116566PMID: 38838545

Targets to Search for New Pharmacological Treatment in Idiopathic Parkinson’s Disease According to the Single-Neuron Degeneration Model

Huenchuguala S, Segura-Aguilar J.

Biomolecules · 2024-06-01

Neurodevelopmental and synaptic defects in DNAJC6 parkinsonism, amenable to gene therapy.

Abela L, Gianfrancesco L, Tagliatti E, Rossignoli G, Barwick K, Zourray C, Reid KM, Budinger D, Ng J, Counsell J, Simpson A, Pearson TS, Edvardson S, Elpeleg O, Brodsky FM, Lignani G, Barral S, Kurian MA.

Brain · 2024-06-01

DOI: 10.1093/brain/awae020PMID: 38242634

The basal forebrain cholinergic system as target for cell replacement therapy in Parkinson's disease.

Björklund A, Barker RA.

Brain · 2024-06-01

DOI: 10.1093/brain/awae026PMID: 38279949

Global trend of nondrug and nonsedativehypnotic treatment forinsomnia: a bibliometric study.

Hanzhou L, Guixing XU, Zepeng W, Ling Z, Fanrong L.

J Tradit Chin Med · 2024-06-01

DOI: 10.19852/j.cnki.jtcm.20240408.002PMID: 38767645

Dopamine synthesis and transport: current and novel therapeutics for parkinsonisms.

Tai MDS, Gamiz-Arco G, Martinez A.

Biochem Soc Trans · 2024-06-01

DOI: 10.1042/bst20231061PMID: 38813865

[Inhaled levodopa: from evidence to experience].

Martínez-Castrillo JC, Pareés-Moreno I, López Sendón-Moreno JL, Pérez-Torre P, Fanjul S, Patiño-Patón A, García-Ribas G, Alonso-Cánovas A.

Rev Neurol · 2024-06-01

DOI: 10.33588/rn.78s01.2024196PMID: 38916176

Application of mesenchymal stem cells for neurodegenerative diseases therapy discovery.

Trinh QD, Mai HN, Pham DT.

Regen Ther · 2024-06-01

DOI: 10.1016/j.reth.2024.09.014PMID: 39524179

Flavonoids as Potential Therapeutics Against Neurodegenerative Disorders: Unlocking the Prospects.

Faysal M, Dehbia Z, Zehravi M, Sweilam SH, Haque MA, Kumar KP, Chakole RD, Shelke SP, Sirikonda S, Nafady MH, Khan SL, Nainu F, Ahmad I, Emran TB.

Neurochem Res · 2024-06-01

DOI: 10.1007/s11064-024-04177-xPMID: 38822985

Neurodegenerative disorders: Mechanisms of degeneration and therapeutic approaches with their clinical relevance.

Gadhave DG, Sugandhi VV, Jha SK, Nangare SN, Gupta G, Singh SK, Dua K, Cho H, Hansbro PM, Paudel KR.

Ageing Res Rev · 2024-06-01

DOI: 10.1016/j.arr.2024.102357PMID: 38830548